Skip to content

MEDTRONIC - 4504M

by Medtronic Cardiac Rhythm Disease Management

PMA P830061

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P830061↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP830061 Date29 Jul 1986ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade Name
Steroid Tip(Tm) Model 4503&4003 Transvenous Pacing
Generic Name
Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
PMA Number
FDA Product Code
NVN
Models / Variants
4504M
Device Class
Class III
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

These devices are drug-eluting permanent transvenous pacemaker electrodes designed for implantation in the right ventricular (RV) or right atrial (RA) chambers. They provide pacing stimulation to regulate cardiac rhythm in patients with bradycardia or conduction system disorders, delivering consistent electrical impulses via a steroid-eluting tip to reduce tissue inflammation and improve electrode stability.

The electrodes are supplied sterile and intended for single-use implantation by qualified healthcare professionals in clinical settings such as cardiac catheterization labs or operating rooms. They are classified as Class III devices under FDA regulations and require a Premarket Approval (PMA) (P830061). Compatibility with MRI is not specified, and proper storage adheres to manufacturer guidelines to maintain sterility and functionality. Sizes and configurations are standardized for transvenous placement via venous access.

Other devices from Medtronic Cardiac Rhythm Disease Management

See all devices from Medtronic Cardiac Rhythm Disease Management →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What specific cardiac chambers are these pacemaker electrodes designed to be implanted in, and how do they differ in function between those chambers?

    These electrodes are designed for implantation in either the **right ventricular (RV)** or **right atrial (RA)** chambers. The primary function remains pacing stimulation to regulate bradycardia or conduction disorders, but the placement differs: RV electrodes target the lower heart chamber to stimulate ventricular contractions, while RA electrodes target the upper chamber to stimulate atrial contractions. Both models feature a **steroid-eluting tip** to reduce tissue inflammation and improve electrode stability, ensuring consistent pacing regardless of chamber placement.

  • Are these electrodes reusable, or are they intended for single-use only? What does this mean for clinical workflows?

    These electrodes are **intended for single-use only** and are supplied sterile for implantation by qualified healthcare professionals. This design ensures patient safety by eliminating risks associated with reuse, such as infection or degradation of electrode performance. Clinically, this means each electrode must be opened and used immediately in a controlled setting like a cardiac catheterization lab or operating room, with proper disposal following use.

  • What storage requirements must be followed to maintain sterility and functionality of these electrodes?

    The electrodes must be stored according to **manufacturer guidelines** to preserve sterility and functionality. Since they are supplied sterile, they should remain in their original packaging until ready for use, protected from contamination, moisture, or physical damage. Exposure to extreme temperatures or prolonged storage beyond the specified shelf life could compromise performance, so adherence to the packaging instructions is critical.

  • How do the steroid-eluting tips on these electrodes benefit patients compared to non-steroid-eluting models?

    The **steroid-eluting tip** reduces tissue inflammation at the implantation site, which helps minimize fibrosis (scarring) around the electrode. This improves long-term electrode stability and pacing consistency, reducing the likelihood of lead dislodgment or failure over time. For patients, this can translate to fewer complications and a lower risk of requiring reoperation or lead revision.

  • What should clinicians consider regarding MRI compatibility when using these electrodes?

    The **MRI compatibility** of these electrodes is **not specified** in the provided data. Clinicians should consult Medtronic’s official guidelines or documentation for the specific models (4003M, 4503M, 4504M, or 4523) before exposing patients to MRI scans. If MRI is required, alternative imaging modalities or precautions may need to be taken to avoid potential risks to the patient or device.